FDA Adverse Event Injury Summary report: N

ELECSYS FOLATE III

MDR report key: 15188515 · Received August 8, 2022

Report

Report Number
1823260-2022-02366
Event Type
Injury
Date Received
August 8, 2022
Date of Event
July 11, 2022
Report Date
September 2, 2022
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CGN
UDI-DI
04015630939695
PMA / PMN Number
K082340
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

OCCUPATION IS ROCHE FIELD APPLICATION SPECIALIST (FAS). ROCHE MEDICAL ASSESSMENT STATES: TOBRAMYCIN OPHTHALMIC OINTMENT IS A TOPICAL ANTIBIOTIC INDICATED WHERE SUPERFICIAL BACTERIAL OCULAR INFECTION OR A RISK OF BACTERIAL OCULAR INFECTION EXISTS. EYE TISSUE DAMAGE DIRECTED FROM OUTSIDE BY A SPLASH OF IRRITANT SUBSTANCE AFFECT PRIMARILY CONJUNCTIVA, CORNEA AND ANTERIOR CAVITY. THE INITIAL INJURY MAY PROMPTLY GET COMPLICATED BY A SECONDARY INFECTION. PREVENTIVE ADMINISTRATION OF TOPICAL ANTIBIOTICS IS A REASONABLE MEDICAL MEASURE WIDELY FOLLOWED. BENEFIT OF PREVENTIVE ANTIBIOTICS OUTWEIGHS THE RISK OF COMPLICATIONS DUE TO INFECTION. PRODUCT LABELING PROVIDES THE METHOD OF PREVENTION: "WEAR PROTECTIVE GLOVES/PROTECTIVE CLOTHING/EYE PROTECTION/FACE PROTECTION." THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE INVESTIGATION DETERMINED THE EVENT WAS DUE TO A PRODUCT HANDLING ISSUE AT THE CUSTOMER SITE.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF AN INJURY TO THE TECHNICIAN WHILE CHECKING FOR FILM ON THE ELECSYS FOLATE III (FOLATE III) REAGENT OF A COBAS E801 MODULE SERIAL NUMBER (B)(4). A FILM ALARM OCCURRED AND THE TECHNICIAN REPORTEDLY REMOVED THE REAGENT FROM THE INSTRUMENT TO CHECK FOR BUBBLES. WHILE CHECKING THE REAGENT, THE TECHNICIAN ALLEGEDLY SPLASHED THE REAGENT IN HER EYE. THE TECHNICIAN WAS WEARING GLOVES AND A LAB COAT; SHE WAS NOT WEARING FACE OR EYE PROTECTION. THE TECHNICIAN FLUSHED HER EYE WITH WATER AND WENT TO THE URGENT CARE CENTER WHERE THEY REPORTEDLY SUGGESTED SHE SEE AN EYE SPECIALIST. THE TECHNICIAN REPORTEDLY SAW AN OPHTHALMOLOGIST WHO PROVIDED HER WITH TOBRAMYCIN EYE OINTMENT. THE OPHTHALMOLOGIST ALLEGEDLY DISCOVERED "DAMAGE" TO HER EYE BUT DID "NOT BELIEVE IT IS PERMANENT." CLARIFICATION WAS REQUESTED RELATED TO THE ALLEGED "DAMAGE" TO THE EYE BUT THE DOCTOR "DID NOT ELABORATE" ON THIS STATEMENT. THE TECHNICIAN IS CURRENTLY REPORTEDLY "DOING OK" AND IS BACK AT WORK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2153990 ELECSYS FOLATE III FOLIC ACID TEST SYSTEM CGN ROCHE DIAGNOSTICS FOLATE G3 ASKU 04015630939695

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention